News Sentiment

CMB sentiment intelligence

Cambium Bio Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 5 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.41 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-6.9% over one week, -5.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Enterprise value to EBITDA forward of Cambium Bio Ltd – ASX:CMB

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -6.9% Price reacting lower
Trend fit Trend inactive -5.8% over four weeks
Fair value -15.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 2
Kalkine 1
simplywall.st 1
intelligentinvestor.com.au 1

Event Lens

What the news is about

Classified themes
Market update 5

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5